We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Draft Guidances on Glucose Meters Could Chill Innovation, Curb Use
FDA Draft Guidances on Glucose Meters Could Chill Innovation, Curb Use
The FDA’s draft guidances for OTC and prescription point-of-care blood glucose tests create overly burdensome clinical trial requirements that may chill development of new products, stakeholders say.